Abiopharma

🔍 Lekstrom Morgan Lee (Director)

Company: Streamex Corp. (STEX)

Report Date: 2026-01-08

Detailed Transactions and Holdings:

• Acquired 100,000 shares of Common stock (Direct)
  Date: 2026-01-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 222,500.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 12,759 shares of Common stock at $1.07 per share (Direct)
  Date: 2026-04-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 209,741.00 | transaction_form_type: 4 | Footnotes: F2, F2

Footnotes:

• F1: Represents a grant of Restricted Stock Units ("RSUs") which were granted on January 8, 2026 (the "Date of Grant"). Each RSU represents the right to receive, at settlement, one (1) share of common stock, par value $0.001 per share, of the Issuer ("Common Stock"). The RSUs vest in four (4) equal quarterly installments over one year with vesting commencing on the Date of Grant, provided that the Reporting Person is still providing services to the Issuer or its subsidiary on such vesting dates.
• F2: The Reporting Person sold the reported shares of Common Stock upon the partial vesting of the RSUs granted on January 8, 2026, solely to satisfy tax withholding obligations incurred upon vesting.